TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2026
Voltar para busca
Dado oficial do USPTO
KD PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
KD PHARMA
ST13
US500000097376275Classe
1, 5, 29
Pedido
97376275
Registro
7593034
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
09/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 29
Data de depósito
22/04/2022
Data de registro
10/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/12/2024
Última transação
09/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
Bexbach, DE
Examinador
KEELEY,ALISON REBECCA
Unidade examinadora
M40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
K.D. Pharma Bexbach GmbH
Representantes
KLAUS P. STOFFEL Lucas & Mercanti, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 29
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Oils and fatslipids used in the manufacture of cosmeticsbeveragesfood productspharmaceuticals and dietary supplements for the manufacture of pharmaceuticalsmedical and veterinary preparationssanitary preparations for medical purposesdietetic foodstuffs and products for medical or veterinary purposesfood supplements for humans and animalsmedicines and natural remediesdietetic preparations and food supplements and pharmaceutical preparations and substancesdietary supplements and dietetic preparationsfood for babies and infantsfor manufacturing beverages for infants and infant formula; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Classe 5
Pharmaceuticalmedical and veterinary preparationspharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorderspharmaceutical products for the prevention and treatment of cancerpharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccineschemical reagents for medical or veterinary purposeschemical reagents for medical or veterinary purposes; sanitary preparations for medical purposes; dietetic foodstuffs and goods for medical or veterinary purposesdietetic foods and beverages adapted for medical usedietetic foods adapted for veterinary usedietetic beverages adapted for veterinary usedietetic preparations adapted for medical purposes; food supplements for humans and animals; disinfectants; medicines and natural remediesnamely medicinal oils and antiallergic medicinesmedicinal preparations for the treatment of infectious diseases and for use in oncologymedicinal drinksmedicinal preparations for infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disordersfor the prevention and treatment of cancerfor the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordersfor the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria- based diseasesfor the treatment of epilepsypainanxietydepressionsleep disordersParkinson's diseasenausea and vomitingfood disordersarthritisPTSDschizophreniaopioid addictionalleviate ALS symptomsmultiple sclerosisfor the treatment of diabetesnatural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; dietetic preparationsnamely Dietetic preparations adapted for medical purposes; food supplements; food for babies; food for infants; infant formula; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Classe 29
Oils and fatsnamely edible oils and edible fats and oils and fats for food; dietetic oils and fats in the nature of edible oils and fatsnot for medical purposes; any cannabis or cannabis derived ingredients in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing containing cannabidiol (CBD)
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2024
PUBO
PUBLISHED FOR OPPOSITION
08/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/09/2024
EXPT
EXPARTE APPEAL TERMINATED
04/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/09/2024
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
01/07/2024
GNSF
SUBSEQUENT FINAL EMAILED
01/07/2024
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
01/07/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/06/2024
EXPI
EX PARTE APPEAL-INSTITUTED
04/06/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/06/2024
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/06/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/03/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/12/2023
GNFR
FINAL REFUSAL E-MAILED
04/12/2023
CNFR
FINAL REFUSAL WRITTEN
04/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
19/06/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
19/06/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/03/2023
GNRT
NON-FINAL ACTION E-MAILED
20/03/2023
CNRT
NON-FINAL ACTION WRITTEN
20/03/2023
DOCK
ASSIGNED TO EXAMINER
01/03/2023
DOCK
ASSIGNED TO EXAMINER
18/02/2023
DOCK
ASSIGNED TO EXAMINER
09/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/04/2022
NWAP
NEW APPLICATION ENTERED
26/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KD PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.